WE SEE THE FUTURE FIRST

WE SEE THE FUTURE FIRST

Minerva Biotechnologies is focused on cancer and stem cell therapeutics. We are developing cancer immunotherapies targeting 80% of solid tumors and to prevent cancer metastasis

more info
patternframe

Welcome to Minerva Biotechnologies

Exploring the Space between Cancers and Stem Cells

Cancer Therapeutics

Cancer Therapeutics

Minerva's CAR T therapeutics will attack solid tumors that are MUC1* positive. This represents approximately 80% of all cancers.

learn more
Regenerative Medicine

Regenerative Medicine

Minerva’s stem cell discoveries will enable pharmaceutical companies to utilize regenerative medicine in a variety of diseases.

learn more
AlphaSTEM®

AlphaSTEM®

Using AlphaSTEM® iPSC generation is more efficient, cell expansion is faster, and differentiation efficiency is increased.

learn more

We See The Future First.

Dr. Cynthia Bamdad Presents at ISCT Montreal. Room 519AB, Thursday, May 3, 2018 at 11:00 AM.

featured news

Dr. Cynthia Bamdad Presents at ISCT Montreal. Room 519AB, Thursday, May 3, 2018 at 11:00 AM.

Dr. Cynthia Bamdad, CEO of Minerva Biotechnologies, will present a talk entitled, “Novel CAR T that Targets MUC1* Not Full-Length MUC1 for...

Posted on May 2, 2018

view more DETAILS

Latest News

May 2, 2018

Dr. Cynthia Bamdad Presents at ISCT Montreal. Room 519AB, Thursday, May 3, 2018 at 11:00 AM.

Dr. Cynthia Bamdad, CEO of Minerva Biotechnologies, will present a talk entitled,

April 26, 2018

Chemist

Minerva Biotechnologies, Bear Hill Rd, Waltham has an immediate opening for a BS or MS

April 26, 2018

(BS/MS) Cancer Cell Scientist

Cancer Cell Scientist (BS/MS) Minerva Biotechnologies is developing therapies

View All News

We See The Future First.

Sign Up For Our Mailing List.